UC

University of California, Davis Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Wednesday, April 3, 2024
Learning, Genetics, UC, Ophthalmology, Research, University, Student, STEM, Genomics, Progressive retinal atrophy, University of California, Davis, Nursing

CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • Meher Khan, a sophomore, studies Genetics and Genomics at the University of California, Davis.
  • We are proud to support that future," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.

Rady Children's Appoints Praveen Raju, MD, PhD, as the Nathan Gordon Chair and Medical Director of Neuro-Oncology Program

Retrieved on: 
Tuesday, April 2, 2024
Research, Diagnosis, Boston Children's Hospital, Brain, Health, Growth, Neurology, MSTP, Memory, Genetics, SAN, Patient, UC, Cancer, Medulloblastoma, Child, University, Neurosurgery, Doctor of Philosophy, Neuro, MD, Molecular biology, NIH, Laboratory, Pediatric neurosurgery, Neoplasm, Infant, Nathan Gordon, Hospital, Spinal cord, Pediatrics, Neuro-Oncology (journal), Medical director, Genetic distance, Nursing

At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.

Key Points: 
  • At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.
  • As part of Rady Children's nationally recognized care team, Dr. Raju will spearhead the growth of the Neuro-Oncology Program and advance research efforts on pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise, Dr. Raju aims to address different forms of pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise into the Neuro-Oncology Program, Dr. Raju aims to address the different forms and distinct molecular subtypes of pediatric brain and spinal tumors.

AS KARMA AUTOMOTIVE CELEBRATES ITS 10TH YEAR … A LOOK BACK AT THE LAST 12 MONTHS AND WHAT'S AHEAD FOR THE SoCAL EV MANUFACTURER

Retrieved on: 
Wednesday, March 27, 2024
University of California, Irvine, Livewire, EV, EVS, Lordstown Motors, Partnership, Karma Automotive, UC, Female, Acquisition, Transport, Entrepreneurship, Software, IP, Karma Revero, Workforce, Harley-Davidson

IRVINE, Calif., March 27, 2024 /PRNewswire/ -- In March 2023, Marques McCammon was named president of Karma Automotive. Back then, the technology manufacturer had produced award-winning exotic vehicle designs for nearly a decade but had yet to reach its full carmaker potential.

Key Points: 
  • IRVINE, Calif., March 27, 2024 /PRNewswire/ -- In March 2023, Marques McCammon was named president of Karma Automotive.
  • Back then, the technology manufacturer had produced award-winning exotic vehicle designs for nearly a decade but had yet to reach its full carmaker potential.
  • Karma has simultaneously reset its brand narrative, direction and vision for the future.
  • Additional Karma milestones during the past year include:
    Launched Engage by Karma as a micro lease business model.

UCI Health celebrates transformational acquisition of four community hospitals

Retrieved on: 
Wednesday, March 27, 2024
University of California, Irvine, Health, Bed, Patient, Education, Public, UC, Hospital, Acquisition, University, Cancer, Doctor of Philosophy, Outline of health sciences, Tenet Healthcare, Eleutherios, FAAP, College of Health Sciences, Safety, Nursing care plan, Physician, Health Affairs, Nursing

ORANGE, Calif., March 27, 2024 /PRNewswire/ -- UCI Health, the clinical enterprise of the University of California, Irvine, has completed the acquisition of four hospitals and associated outpatient locations from Tenet Healthcare Corporation. Beginning today, the team members at Fountain Valley Regional Hospital, Lakewood Regional Medical Center Los Alamitos Medical Center and Placentia-Linda Hospital are now part of UCI Health.

Key Points: 
  • We celebrate the transformation of UCI Health as a leader in the integration of academic and community-based health systems while promoting solutions to challenges facing healthcare," said UC Irvine Chancellor Howard Gillman.
  • As Orange County's only academic health system, UCI Health plays a unique and critical role providing healthcare in the region.
  • "UCI Health has built a legacy as a nationally regarded academic health system that is fiercely dedicated to improving the health of our communities.
  • Lefteris said UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by these hospitals.

Algenesis Unveils Groundbreaking Biodegradable TPU Material, Pioneering a Future Without Microplastics

Retrieved on: 
Thursday, March 21, 2024
Research, Health, Microplastics, Toxicology, Scientific Reports, Nutrient, Environment, Recycling, UCSD, Partnership, SAN, UC, Trelleborg, Mortality, Bacteria, University, TPU, Nature, Carbon, Shoe, Plastic, Microbiology, Petroleum, Soil, Agriculture

These findings point to an urgent need to remove existing microplastics from the environment, while simultaneously adopting sustainable materials that do not produce these persistent microplastics.

Key Points: 
  • These findings point to an urgent need to remove existing microplastics from the environment, while simultaneously adopting sustainable materials that do not produce these persistent microplastics.
  • Algenesis' latest breakthrough is the development of a bio-based TPU that directly addresses the microplastics crisis thanks to its biodegradability.
  • Algenesis demonstrated in its study that tiny plastic particles from this new TPU are able to rapidly biodegrade under home composting conditions.
  • Algenesis' biodegradable TPU material represents a major leap forward in reducing the production and accumulation of microplastics, thus safeguarding our ecosystems and human health.

MARAbio appoints Gail S. Page as member of Board of Directors

Retrieved on: 
Thursday, March 14, 2024
Labcorp, Incidence, Physician, UC, Vermilion, Child, Pregnancy, Luminex, Water, MIND, University of California, Davis, Spectrum, Parent, Management

SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio, whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors. Ms. Page has more than 30 years of life sciences experience, and currently serves as a partner at pH Blueprint, a strategic advisory firm focused on collaborating with medical device, diagnostics, and biotech clients. She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm. Previously Ms. Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc. Her current and past board appointments include public and private companies.

Key Points: 
  • SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio , whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors.
  • She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm.
  • Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc.
  • "Gail brings significant insights and experience in the diagnostic and clinical lab sectors as a former CEO and other C-level positions, and we are very pleased to welcome her to MARAbio's Board of Directors," said Marnin Kligfeld, Chairman of the Board of MARAbio.

Alianza Announces 2024 Omdia Research Report "Reinventing Core Communications: Strategic Imperatives for Growth"

Retrieved on: 
Tuesday, March 12, 2024
Cloud, Synthetic media, Natural language processing, Face, Capital expenditure, Risk, UC, Internet, OPEX, Marketplace, Gross domestic product, Risk assessment, Workforce, Telecommunications, Human

PLEASANT GROVE, Utah, March 12, 2024 /PRNewswire/ -- Alianza, Inc., the leading cloud communications platform for service providers, today released a new Omdia Research report, "Reinventing Core Communications: Strategic Imperatives for Growth." The report offers a transformation roadmap for telcos as they face increasing operational complexity, network costs, and revenue pressures that are creating unsustainable market conditions and threatening business growth. 

Key Points: 
  • "The risk of doing nothing now outweighs lagging concerns about migrating core communications to the cloud.
  • Over the past decade, net global telecom revenue has stagnated, declining to $1.98 trillion in 2022, from $1.99 trillion in 2014.
  • Service providers often overlook core communications as an area ripe for innovation but can no longer afford to hold off.
  • Cloud transformation: The cost and risks of maintaining legacy voice infrastructure have become too high, furthering the shift to vendor-hosted clouds for core communications.

Reinvent Telecom Partners with NetSapiens to Deliver a Next-Gen White-Label UC&C Platform

Retrieved on: 
Monday, March 11, 2024
Microsoft, NOC, Conference, UC, LAS, Microsoft Teams, Telecom, SIP, Video game

SCOTTSDALE, Ariz. and LAS VEGAS, March 11, 2024 /PRNewswire-PRWeb/ -- Reinvent Telecom, a provider of wholesale unified communications, SIP trunking, business messaging, direct routing for Microsoft Teams and contact center as a service solutions, announced today at the Channel Partners Conference & Expo in Las Vegas, that it has partnered with NetSapiens, a leading cloud-native communications platform provider, to deliver next-generation unified communications and collaboration (UC&C) solutions to its community of reseller partners.

Key Points: 
  • "The addition of the NetSapiens platform offers our [Reinvent's] reseller partners next-generation capabilities, flexibility and cost-efficiencies that can help them to grow their white-label wholesale or cobranded cloud communications businesses."
  • "We're thrilled to partner with NetSapiens on the rollout of Reinvent's new unified communications and collaboration platform," said Bill Bryant, President of Reinvent Telecom and Saddleback Communications.
  • NetSapiens is an award-winning, patented cloud-native communications platform that offers Reinvent and its reseller partners a high-availability, multitenant solution with more than 4 million active users around the globe.
  • Reinvent plans to roll out the NetSapiens platform to its partners later this year.

US monetary policy is more powerful in low economic growth regimes

Retrieved on: 
Tuesday, April 2, 2024
Tao, Research Papers in Economics, Excess, American Economic Journal, Doan, Policy, RT, Interpolation, Economic growth, Absorption, Business, E32, Low, Browning, European Economic Review, UST, NBER, Forecasting, Macroeconomics, European Economic Association, Journal of Monetary Economics, Journal of Applied Econometrics, TVAR, Oxford University Press, Time series, Economic Inquiry, Paper, Linearity, Joshua Angrist, Nobuhiro, Environment, Political economy, Journal of Financial Economics, Rated R, R2, Website, Emi, Energy economics, Probability, Medical classification, Eurozone, Sigismund, Quarterly Journal of Economics, Zero lower bound, History, Nature, Chapter, ZT, Journal of Political Economy, Bocconi University, OLS, Statistics, University of California, Irvine, PDF, Classification, ECB, XS, ITP, Impact, Estimation, DGP, Mark Thoma, Social science, Elsevier, JEL, Cambridge University Press, Real, M1, Research, Textbook, Private sector, FED, Credit, UTT, Literature, Federal Reserve, Knotek, Evelyn Regner, Table, European Central Bank, Chow, FRED, Monetary economics, Wald, Ben Bernanke, Premium, P500, BIS, EWMA, International Economic Review, Federal funds rate, Money, Treasury, C32, The Economic Journal, Federal Reserve Economic Data, Employment, Risk, FFR, Suggestion, FOMC, Monte Carlo method, Sigmoid, VAR, Database, Projection, Ascari, The Journal of Finance, Yield curve, United States Treasury security, Economy, Fed, Figure, NFCI, Financial economics, EXP, Freedom, Central bank, PCE, Monetary policy, American Economic Review, Exercise, Interest, Samuel, URR, Rigidity, Business cycle, XT, Landing slot, Chap, Daron Acemoglu, Markov, Blue chip, Kuttner, Response, Quarterly Journal, YT, Channel, GDP, Standard, Effect, Federal, Cost, Christian Social Union (UK), Journal of Econometrics, Comm, Mark Gertler, Use, Economic statistics, IW, Bank for International Settlements, Finance Secretary (India), UC, Bank, Reproduction, Section, News, Housing, Data, Food industry
Key Points: 

    EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

    Retrieved on: 
    Wednesday, March 13, 2024
    Janus, Psoriasis, Research, Webcast, German, MRI, General assembly, Biotechnology, Calcium, Expense, Regeneration, Capital punishment, SIRT6, Conference, Biomarker, AFL, Patent, PMS, Histology, Clinical trial, Investment, Ulcerative colitis, Magnetic resonance imaging, SPMS, Research and development, Multiple sclerosis, UC, Administration, Patient, Disease, RMS, Pharmaceutical industry

    The highly encouraging results demonstrated clear separation from placebo in serum neurofilament light chain (NfL) levels in patients with progressive multiple sclerosis (PMS).

    Key Points: 
    • The highly encouraging results demonstrated clear separation from placebo in serum neurofilament light chain (NfL) levels in patients with progressive multiple sclerosis (PMS).
    • The results demonstrated meaningful improvements over placebo in four key dimensions of celiac disease pathophysiology: histology, disease symptoms, biomarkers and nutrient absorption.
    • Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access.
    • An archived replay of the webcast will be available approximately one hour after completion on Immunic’s website at: ir.imux.com/events-and-presentations .